Cytochrome P450 2C19 681G > A polymorphism in coronary heart disease patients treated with clopidogrel in Chinese

被引：0
|
作者：
Tang, Xiaofang
Yuan, Jinqing
Yang, Yuejin
机构：
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Peking Union Med Coll, Beijing 100037, Peoples R China
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [1] CYTOCHROME P450 2C19 681G>A POLYMORPHISM IN CORONARY HEART DISEASE PATIENTS TREATED WITH CLOPIDOGREL IN CHINESE
    Tang, Xiaofang
    Yuan, Jinqing
    Yang, Yuejin
    He, Chen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1206 - E1206
  • [2] Effect of Cytochrome P450 2C19 681G > A Polymorphism on Premature Coronary Heart Disease
    Chi, Zhong-Hai
    Li, Yuan-Yuan
    Li, Juan
    Zhang, Zheng
    Jia, Li
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2015, 5 (02) : 55 - 59
  • [3] Association between cytochrome P450 2C19 681G>A polymorphisms and risk of cardiovascular events in coronary heart disease with clopidogrel in Chinese
    Yuan, J.
    Tang, X. F.
    Yang, Y. J.
    Gao, R. L.
    EUROPEAN HEART JOURNAL, 2011, 32 : 238 - 238
  • [4] Relation of cytochrome P450 2C19 gene 681G>A single nucleotide polynmrphism to clopidogrel resistance after PCI in Chinese
    LIANG Zhen-yang
    岭南心血管病杂志, 2011, (S1) : 155 - 155
  • [5] Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
    Bo Jin
    Huan-Chun Ni
    Wei Shen
    Jian Li
    Hai-Ming Shi
    Yong Li
    Molecular Biology Reports, 2011, 38 : 1697 - 1702
  • [6] Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
    Jin, Bo
    Ni, Huan-Chun
    Shen, Wei
    Li, Jian
    Shi, Hai-Ming
    Li, Yong
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (03) : 1697 - 1702
  • [7] Cytochrome P450 2C19 polymorphism and clopidogrel after MI
    Bhattacharyya, Sanjeev
    Rakhit, Roby
    LANCET, 2009, 373 (9670): : 1171 - 1171
  • [8] Cytochrome P450 2C19 polymorphism in Iranian patients with coronary artery disease
    Akhlaghi, Arash
    Shirani, Shahin
    Ziaie, Naghmeh
    Pirhaji, Omid
    Yaran, Majid
    Shahverdi, Golnoosh
    Sarrafzadegan, Nizal
    Khosravi, Alireza
    Khosravi, Elham
    ARYA ATHEROSCLEROSIS, 2011, 7 (03) : 106 - 110
  • [9] CYP2C19 681G > A polymorphism and pharmacokinetics of clopidogrel in Chinese healthy volunteers
    Zou Jian-Jun
    Ding Li
    Tan Jie
    He BangShun
    Wang Guang-Ji
    Wang Shu-Kui
    PHARMAZIE, 2012, 67 (09): : 795 - 797
  • [10] Relation between cytochrome P450 2C19 681 G>A polymorphism, platelet responsiveness to adp and clinical outcome after elective percutaneous coronary intervention in patients treated with clopidogrel
    Pouplard, C.
    Blicq, E.
    Regina, S.
    de Labriolle, A.
    Charbonnier, B.
    Gruel, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1054 - 1054
12345